Paolo Morelli has moved from his position as CEO and President of CROS NT to Chairman. He will focus on PMH, a holding company which oversees other life sciences businesses including ARITHMOS, a provider of IT services for clinical trials.
"There are some great things happening within PMH and the time is right for me to dedicate more time to this project,” said Morelli.
“I intend to work closely with ARITHMOS next year; the life sciences technology space has always excited me. Within ARITHMOS, we have the right portfolio of technologies and I want to make sure we are connecting with the market and getting these products to our customers."